Xpantoz-DSR Capsule

Xpantoz Dsr Capsule is a pharmaceutical combination tablet containing Domperidone and Pantoprazole. This dual-action medication is designed to treat conditions characterised by excessive stomach acid production and impaired movement of food through the digestive tract.

• Pantoprazole is a Proton Pump Inhibitor (PPI) that works by powerfully reducing the amount of acid produced in the stomach.

• Domperidone is a prokinetic agent that enhances the movement (motility) of the stomach and upper intestine, helping food move down faster and preventing reflux.

This combination is primarily prescribed for the treatment of severe Gastroesophageal Reflux Disease (GERD), where acid reflux is accompanied by symptoms of delayed stomach emptying, as well as for treating Non-Ulcer Dyspepsia (indigestion) and preventing Peptic Ulcer Disease, when vomiting or nausea is also present.

Xpantoz Dsr Capsule provides synergistic relief by combining two distinct pharmacological classes in one tablet, addressing both the chemical (acid) and mechanical (motility) components of upper gastrointestinal distress.

1. Pantoprazole- The Acid Reducer

Pantoprazole is one of the most effective PPIs. It works by irreversibly binding to the Hydrogen-Potassium ATPase enzyme (the proton pump) located on the surface of the parietal cells in the stomach lining. This pump is the final step in acid secretion. By blocking this pump, Pantoprazole effectively shuts down acid production, providing sustained, superior acid control that is often superior to that of H2-receptor blockers. This is essential for healing ulcers and soothing the acid-damaged oesophagus in GERD.

2. Domperidone- The Motility Enhancer

Domperidone acts as a dopamine D2 receptor antagonist. It primarily works in the upper digestive tract, increasing the tone of the lower oesophageal sphincter (the muscle valve that prevents acid from backing up) and accelerating the movement of the stomach muscles. This action:

• Speeds up Gastric Emptying: Reduces the time food and acid spend in the stomach.

• Reduces Reflux: Strengthens the barrier against acid reflux.

• Alleviates Nausea/Vomiting: Blocks dopamine receptors in the area of the brain that controls nausea (chemoreceptor trigger zone).

The combination in Xpantoz Dsr Capsule is particularly beneficial because Domperidone helps clear acid from the stomach more quickly. In contrast, Pantoprazole helps reduce acid production, providing comprehensive relief for complex reflux and motility disorders.

Xpantoz Dsr Capsule (Domperidone + Pantoprazole Tablet) is indicated for the treatment of:

• Gastroesophageal Reflux Disease (GERD): Specifically, when accompanied by symptoms of nausea, vomiting, or delayed gastric emptying.

• Reflux Oesophagitis: The inflammation and damage to the lining of the oesophagus caused by chronic acid reflux.

• Erosive Oesophagitis: Severe GERD where tissue erosion has occurred.

• Non-Ulcer Dyspepsia (Indigestion): Symptoms like upper abdominal pain, bloating, fullness, and excessive burping, where poor motility is suspected.

• Zollinger-Ellison Syndrome (ZES): Used for long-term management of this condition involving excessive acid secretion.

The combination of Pantoprazole and Domperidone provides comprehensive benefits not available in single-ingredient treatments.

• Dual-Action Relief: It addresses both excessive stomach acid (Pantoprazole) and impaired digestive movement (Domperidone), leading to superior control of reflux and nausea symptoms.

• Rapid Healing: The potent acid suppression allows the inflamed and eroded tissues in the oesophagus and stomach to heal more quickly.

• Reduced Nausea and Vomiting: Domperidone effectively controls the associated symptoms of nausea and vomiting, which are common in severe GERD and motility disorders.

• Enhanced Barrier Function: Domperidone strengthens the lower oesophageal sphincter, physically reducing the chance of acid backflow.

• Convenient Dosing: Combining the two medicines into one tablet improves patient adherence to the treatment plan.

While generally effective, this combination can lead to side effects, some of which are specific to each component.

Common Side Effects (Usually Mild and Transient):

• Gastrointestinal Distress: Dry mouth, constipation, or diarrhoea (more common with Pantoprazole).

• Headache and Dizziness (familiar with both components).

• Flatulence (gas).

• Weakness or Fatigue.

Serious Side Effects (Stop treatment and seek urgent medical attention if you experience):

• Cardiac Issues (Domperidone Risk): Palpitations, irregular heartbeat (arrhythmia), or fainting. Domperidone is associated with a small risk of serious ventricular arrhythmias and is often restricted in use.

• Severe Allergic Reactions: Rash, swelling of the face, tongue, or throat, or difficulty breathing.

• Vitamin B12 Deficiency (Long-term PPI Use): Persistent fatigue, numbness, or tingling.

Bone Fractures (Long-term PPI Use): Increased risk of hip, wrist, or spine fractures with use beyond one year.

Xpantoz Dsr Capsule is an oral tablet and must be taken exactly as prescribed by your doctor.

• Take Before Food: The tablet should be taken once daily, preferably 15 to 30 minutes before your first meal of the day (breakfast). This timing is crucial for Pantoprazole to be most effective, as it must reach the parietal cells before they are activated by eating.

• Swallow Whole: The tablet must be swallowed whole with a glass of water. Do not chew, crush, or break the tablet, as this can destroy the enteric coating of the Pantoprazole component.

• Duration: Do not stop taking the medicine suddenly, even if you feel better. Your doctor will determine the appropriate duration, which should generally be as short as possible, especially for the Domperidone component.

• Maximum Domperidone Duration: Due to cardiac risks, Domperidone is generally not recommended for more than 1 week, though Pantoprazole may continue separately.

• Prioritise Timing: Always take this tablet in the morning, 15 to 30 minutes before breakfast, for the best acid-reducing effect.

• Report Heart Symptoms: Due to the cardiac risk associated with Domperidone, immediately report any unexplained palpitations, racing heart, or fainting spells to your doctor.

• Avoid Long-Term Use of Domperidone: Domperidone should generally be limited to short-term use (e.g., 1-2 weeks) unless specifically prescribed by a specialist. Discuss transitioning to Pantoprazole-only therapy if symptoms permit.

• Lifestyle Changes: This medicine works best when combined with lifestyle modifications: avoid lying down immediately after eating, elevate the head of your bed, and avoid trigger foods (spicy, fatty, caffeine, and chocolate).

• Do not Stop Abruptly: Stopping the Pantoprazole component suddenly can lead to "rebound acid hypersecretion," causing symptoms to return strongly. Follow your doctor's instructions for tapering the dose.

• Store the tablets in their original packaging at room temperature, typically below 25 °C to 30 °C.

• Keep them protected from moisture and heat.

• Ensure the medication is stored out of reach and out of sight of children and pets.

• Food: The medication must be taken before food (15-30 minutes before breakfast). Taking it with or after food will significantly reduce Pantoprazole's effectiveness.

• Calcium/Magnesium: Long-term use of PPIs may affect the absorption of certain minerals, including Calcium and Magnesium. Your doctor may recommend supplementation.

• Drugs that Prolong the QT Interval: Contradication. Combining Domperidone with medications that affect heart rhythm (e.g., certain antibiotics such as erythromycin, antifungals such as ketoconazole, or specific antiarrhythmics) is strictly contraindicated due to an increased risk of heart rhythm disturbances.

• CYP3A4 Inhibitors: Medications that slow the metabolism of Domperidone (e.g., specific HIV protease inhibitors, some azole antifungals) are contraindicated because they increase Domperidone concentrations and cardiac risk.

• Methotrexate: Pantoprazole may increase the blood levels of Methotrexate (a chemotherapy drug), requiring close monitoring, especially at high doses.

• Clopidogrel: Pantoprazole may interfere with the activation of Clopidogrel (a blood thinner), potentially reducing its effectiveness. Consult your doctor if you are on this medication.

The combination is contraindicated or requires extreme caution in patients with:

• Heart Conditions: Patients with heart failure, a recent heart attack, or an existing prolonged QT interval are advised against using Domperidone due to the risk of serious cardiac arrhythmias.

• Moderate to Severe Liver Impairment: Contraindicated due to impaired metabolism of Domperidone.

• Gastrointestinal Haemorrhage/Blockage: Domperidone's prokinetic action could be harmful if there is a known GI bleeding, obstruction, or perforation.

The standard dose for adults is one tablet (Domperidone + Pantoprazole) once daily, taken before breakfast.

The duration of the Domperidone component is often limited to the shortest period necessary (usually 7 days) to control acute symptoms of nausea and vomiting, after which treatment may continue with Pantoprazole alone.

An overdose can be severe due to the potential cardiac effects of Domperidone.

• Symptoms: May include extreme drowsiness, confusion, uncontrolled body movements, slurred speech, or cardiac rhythm disturbances.

• Action: If an overdose is suspected, seek emergency medical care immediately. Treatment will focus on supportive measures and cardiac monitoring.

If you miss a dose of Xpantoz Dsr Capsule:

• Take the missed dose as soon as you remember, if it is still before your first meal of the day.

• If it is already past breakfast time or close to your next scheduled dose, skip the missed dose and continue with your regular morning schedule.

• Do not take two doses at the same time.